Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
AIDS Research and Human Retroviruses|June 28, 2013
Effects of raltegravir on 2-long terminal repeat circle junctions in HIV type 1 viremic and aviremic patientsRoberta Bona, Silvia Baroncelli, Gabriella D'Ettorre, et al.
NPJ Vaccines|June 2, 2023
Antiviral effect of SARS-CoV-2 N-specific CD8Francesco Manfredi, Chiara Chiozzini, Flavia Ferrantelli, et al.
Molecular Therapy. Methods & Clinical Development|November 3, 2021
Safety and efficiency modifications of SIV-based integrase-defective lentiviral vectors for immunizationRoberta Bona, Zuleika Michelini, Chiara Mazzei, et al.
Viruses|March 6, 2021
Integrase-Defective Lentiviral Vector Is an Efficient Vaccine Platform for Cancer ImmunotherapyValeria Morante, Martina Borghi, Iole Farina, et al.
Biomolecules|January 25, 2025
A New Antibody-Cytokine Construct Targeting Natural Killer Cells: An Immunotherapeutic Approach to Chronic Lymphocytic LeukemiaMichela Flego, Mauro Andreotti, Francesca Romana Mauro, et al.
Journal of Medical Virology|May 21, 2016
HIV-1 DNA dynamics and variations in HIV-1 DNA protease and reverse transcriptase sequences in multidrug-resistant patients during successful raltegravir-based therapyZuleika Michelini, Clementina Maria Galluzzo, Maria Franca Pirillo, et al.
International Journal of Environmental Research and Public Health|January 11, 2022
UltraViolet SANitizing System for Sterilization of Ambulances Fleets and for Real-Time Monitoring of Their Sterilization LevelZuleika Michelini, Chiara Mazzei, Fabio Magurano, et al.
HIV Clinical Trials|January 8, 2016
Reduced Plasma Levels of sCD14 and I-FABP in HIV-infected Patients with Mesalazine-treated Ulcerative ColitisZuleika Michelini, Silvia Baroncelli, Alessandra Fantauzzi, et al.
Journal of Virological Methods|June 19, 2010
Evaluation of HIV-1 integrase inhibitors on human primary macrophages using a luciferase-based single-cycle phenotypic assayZuleika Michelini, Clementina Maria Galluzzo, Donatella R M Negri, et al.
Retrovirology|January 23, 2015
Endogenous CCL2 neutralization restricts HIV-1 replication in primary human macrophages by inhibiting viral DNA accumulationMichela Sabbatucci, Daniela Angela Covino, Cristina Purificato, et al.
Pageof 5